Skip to content

Perioperative pain management of gynecological patients

The application of multimodal analgesia in patients with gynecological surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17010424
Enrollment
Unknown
Registered
2017-01-13
Start date
2014-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperatival pain

Interventions

Laparoscopic treatment group:Multimodal analgesia
the control group of laparoscopic:None
laparotomy treatment group:Multimodal analgesia
the control group of laparotomy:None

Sponsors

Obstetrics and Gynecology Department of the Second Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. gynecological laparoscopy or laparotomy, vaginal surgery patients; 2. aged 18 years old or more.

Exclusion criteria

Exclusion criteria: 1. sodium for injection with parry smoothie cloth active ingredients or excipient in any of the ingredients in patients with a history of allergies; 2. history of serious drug allergy reaction, especially skin reactions, such as eyes, skin and mucosa syndrome (Stevens Johnson syndrome), toxic epidermal necrosis release, erythema multiforme, etc., or known allergic to sulfa drugs; 3. the patients of bronchospasm, acute rhinitis, nasal polyps, angioneurotic oedema, urticaria and other allergic reaction after use aspirin and non-steroidal anti-inflammatory drugs (including cox-2 inhibitors); 4. congestive heart failure (NYHA II - IV); 5. after coronary artery bypass surgery for the treatment of postoperative pain; 6. has determined the ischemic heart disease, peripheral arterial blood vessels and/or cerebrovascular disease; 7. active peptic ulcer or gastrointestinal bleeding; 8. severe liver function damage (serum albumin < 25 g/l or Child - Pugh score 10 or higher); 9. inflammatory bowel disease; 10. pregnant or lactating patients.

Design outcomes

Primary

MeasureTime frame
Pain score;Anxiety depression score;Postoperative adverse reactions;

Secondary

MeasureTime frame
blood routine examination;

Countries

China

Contacts

Public ContactBing Wei

Obstetrics and Gynecology Department of the Second Hospital of Anhui Medical University

wbfck1965@163.com+86 13615696088

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026